Novartis and Uni of Oxford to join forces and use AI for diseases and drug development

"Novartis and the University of Oxford’s Big Data Institute have announced that they are to establish a five-year research alliance using artificial intelligence to understand complex diseases and improve drug development. The alliance plans to analyse huge data sets using artificial intelligence and machine learning to spot disease insights that have been undetectable to scientists thus far, expecting to transform how ultra large and multiple datasets are analysed, combined and interpreted to identify early predictors of patient responses to treatments for inflammatory diseases, such as multiple sclerosis (MS) and psoriasis..." Lire la suite